Skip to content

Physician Referral

BAMF Health utilizes the world’s most advanced technology in the only dedicated Theranostics center in the United States.

We perform diagnostic scans and administer radioligand therapy for metastatic prostate cancer and neuroendocrine cancer.

We perform diagnostic scans that can offer the most advanced staging available for patients suffering from all forms of cancer.

Providers can now order PET/CT scans at BAMF Health’s Molecular Imaging Clinic
Providers can now refer patients to BAMF Health’s Molecular Therapy Clinic
Providers can now refer patients to BAMF Health’s Advanced Clinical Trials

Molecular Imaging Clinic

Providers can now order PET/CT scans at BAMF Health’s Molecular Imaging Clinic, utilizing the uExplorer Total Body PET/CT – the only scanner of its kind in clincal use in the United States.

Capable of total body scans in under 60 seconds. Improves patient experience and potentially eliminates claustrophobia. Capable of any PET/CT Study: FDG, PSMA, Ga68-Dotatate.

40x more sensitive than traditional PET scanning technology. Better images could change staging or avoid unnecessary procedures.

Molecular Therapy Clinic

Providers can now refer patients for Theranostics at the BAMF Health Molecular Therapy Clinic

Pluvicto® (Lu-177-PSMA-617) indicated for metastatic castration resistant prostate cancer post hormone therapy and taxane-based chemotherapy

Lutathera® (Lu-177-DOTATATE) for treatment of gastroenteropancreatic neuroendocrine tumor (GEP-NET)

Post-therapy Dosimetry utilizing world’s most advanced digital SPECT/CT, GE Starguide

Advanced Clinical Trials

Providers can now refer patients to BAMF Health’s Advanced Clinical Trials.

BAMF Health is Now Enrolling Patients in the ECLIPSE Trial for Prostate Cancer Patients.

Additional trials will be initiated in 2023. Please check back soon for additional details.